1. Home
  2. XBIT vs IDN Comparison

XBIT vs IDN Comparison

Compare XBIT & IDN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo XBiotech Inc.

XBIT

XBiotech Inc.

SELL

Current Price

$2.20

Market Cap

66.8M

Sector

Health Care

ML Signal

SELL

Logo Intellicheck Inc.

IDN

Intellicheck Inc.

SELL

Current Price

$2.21

Market Cap

56.5M

Sector

Technology

ML Signal

SELL

Company Overview

Basic Information
Metric
XBIT
IDN
Founded
2005
1994
Country
United States
United States
Employees
N/A
N/A
Industry
Pharmaceuticals and Biotechnology
Computer Software: Prepackaged Software
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
66.8M
56.5M
IPO Year
2015
2014

Fundamental Metrics

Financial Performance
Metric
XBIT
IDN
Price
$2.20
$2.21
Analyst Decision
Buy
Analyst Count
0
3
Target Price
N/A
★ $4.83
AVG Volume (30 Days)
25.8K
★ 221.0K
Earning Date
11-11-2026
11-11-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 220.00
EPS
N/A
★ 0.06
Revenue
N/A
★ $4,433,454.00
Revenue This Year
N/A
N/A
Revenue Next Year
$30.47
N/A
P/E Ratio
★ N/A
$38.25
Revenue Growth
N/A
★ 23.21
52 Week Low
$2.09
$2.24
52 Week High
$3.44
$9.08

Technical Indicators

Market Signals
Indicator
XBIT
IDN
Relative Strength Index (RSI) 50.35 26.67
Support Level $2.19 N/A
Resistance Level $2.48 $2.46
Average True Range (ATR) 0.03 0.08
MACD 0.01 0.02
Stochastic Oscillator 70.00 0.00

Price Performance

Historical Comparison
XBIT
IDN

About XBIT XBiotech Inc.

XBiotech Inc is a biopharmaceutical company that discovers and develops True Human monoclonal antibodies derived from human donors to replicate the human immune response in the treatment of various diseases. It has developed a pipeline of product candidates using True Human antibodies targeting both inflammatory and infectious diseases. The company's developement pipeline comprises: Natrunix, an antibody targeting IL-1a in oncology (pancreatic cancer), a clinical stage therapeutic for Methicillin Resistant Staphylococcus aureus (MRSA), and several pre-clinical stage therapeutics, including: an oral delivery antibody therapeutic for colon infection by C. difficile; an injectable therapy for varicella zoster (adult chicken pox), the causative agent for shingles; and an influenza therapy.

About IDN Intellicheck Inc.

Intellicheck Inc is a trusted industry leader in technology solutions that stop identity theft and fraud with real-time identification authentication and age verification. The group delivers on-demand digital and physical identity verification solutions for KYC, AML, fraud prevention, and age verification needs. The products of the company includes solutions for preventing identity fraud across any industry delivered via smartphone, tablet, POS integration or other electronic devices.

Share on Social Networks: